Skip to main content
. 2020 Jan;72(1):1–49. doi: 10.1124/pr.118.016899

Fig. 7.

Fig. 7.

Orthosteric ligand-binding site in CRTH2. The crystal structures of human CRTH2 bound to fevipiprant (left, Supplemental Material 1-PDB ID 6D26) and CAY10471 (right, Supplemental Material 1-PDB ID 6D27) revealed the molecular details of ligand binding in the orthosteric ligand-binding site.